Efficacy and safety of seltorexant as adjunctive therapy in patients with major depressive disorder: Results from a phase 2b, randomized, placebo-controlled, parallel-group, adaptive dose-finding study

Authors
Category Primary study
ConferenceNeuropsychopharmacology
Year 2019
This article has no abstract
Epistemonikos ID: 9b0436bd176c9a997e5824ba099c5a6e278347ef
First added on: Apr 29, 2026